Qingxi Wang
Director/Board Member at CSPC PHARMACEUTICAL GROUP LTD.
Net worth: 2 M $ as of 30/04/2024
Profile
Qingxi Wang is currently the Chairman & Chief Executive Officer at Conjupro Biotherapeutics, Inc. and an Executive Director at CSPC Pharmaceutical Group Ltd.
Previously, he worked as a Director of Operations & Business Development at Merck & Co., Inc. Dr. Wang holds a Master's in Business Administration from Temple University, a graduate and doctorate degree from the University of Connecticut, and undergraduate and graduate degrees from Nankai University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/11/2023 | 3,000,000 ( 0.03% ) | 2 M $ | 30/04/2024 |
Qingxi Wang active positions
| Companies | Position | Start |
|---|---|---|
| CSPC PHARMACEUTICAL GROUP LTD. | Director/Board Member | 20/08/2018 |
Conjupro Biotherapeutics, Inc.
 Conjupro Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Conjupro Biotherapeutics, Inc. is a biopharmaceutical company that specializes in clinical research and drug development. The company is based in Princeton, NJ. Qingxi Wang has been the CEO of the company since 2016. | Chief Executive Officer | 01/01/2016 |
Former positions of Qingxi Wang
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Chief Operating Officer | - |
Training of Qingxi Wang
| Temple University (Pennsylvania) | Masters Business Admin |
| University of Connecticut | Doctorate Degree |
| Nankai University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| CSPC PHARMACEUTICAL GROUP LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Conjupro Biotherapeutics, Inc. is a biopharmaceutical company that specializes in clinical research and drug development. The company is based in Princeton, NJ. Qingxi Wang has been the CEO of the company since 2016. | Commercial Services |
- Stock Market
- Insiders
- Qingxi Wang